Literature DB >> 24898246

Endocytotic routes of cobra cardiotoxins depend on spatial distribution of positively charged and hydrophobic domains to target distinct types of sulfated glycoconjugates on cell surface.

Shao-Chen Lee1, Chien-Chu Lin2, Chia-Hui Wang3, Po-Long Wu3, Hsuan-Wei Huang3, Chung-I Chang4, Wen-guey Wu5.   

Abstract

Cobra cardiotoxins (CTX) are a family of three-fingered basic polypeptides known to interact with diverse targets such as heparan sulfates, sulfatides, and integrins on cell surfaces. After CTX bind to the membrane surface, they are internalized to intracellular space and exert their cytotoxicity via an unknown mechanism. By the combined in vitro kinetic binding, three-dimensional x-ray structure determination, and cell biology studies on the naturally abundant CTX homologues from the Taiwanese cobra, we showed that slight variations on the spatial distribution of positively charged or hydrophobic domains among CTX A2, A3, and A4 could lead to significant changes in their endocytotic pathways and action mechanisms via distinct sulfated glycoconjugate-mediated processes. The intracellular locations of these structurally similar CTX after internalization are shown to vary between the mitochondria and lysosomes via either dynamin2-dependent or -independent processes with distinct membrane cholesterol sensitivity. Evidence is presented to suggest that the shifting between the sulfated glycoconjugates as distinct targets of CTX A2, A3, and A4 might play roles in the co-evolutionary arms race between venomous snake toxins to cope with different membrane repair mechanisms at the cellular levels. The sensitivity of endocytotic routes to the spatial distribution of positively charged or hydrophobic domains may provide an explanation for the diverse endocytosis pathways of other cell-penetrating basic polypeptides.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cardiotoxin; Cholesterol; Endocytosis; Heparan Sulfate; Snake Venom; Sulfatide; X-ray Crystallography

Mesh:

Substances:

Year:  2014        PMID: 24898246      PMCID: PMC4106332          DOI: 10.1074/jbc.M114.557157

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Studies on the internalization mechanism of cationic cell-penetrating peptides.

Authors:  Guillaume Drin; Sylvine Cottin; Emmanuelle Blanc; Anthony R Rees; Jamal Temsamani
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Structural basis of citrate-dependent and heparan sulfate-mediated cell surface retention of cobra cardiotoxin A3.

Authors:  Shao-Chen Lee; Hong-Hsiang Guan; Chia-Hui Wang; Wei-Ning Huang; Siu-Cin Tjong; Chun-Jung Chen; Wen-guey Wu
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

5.  Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage.

Authors:  Alexei V Feofanov; George V Sharonov; Maria V Astapova; Dmitriy I Rodionov; Yuriy N Utkin; Alexander S Arseniev
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

6.  Cationic TAT peptide transduction domain enters cells by macropinocytosis.

Authors:  Ian M Kaplan; Jehangir S Wadia; Steven F Dowdy
Journal:  J Control Release       Date:  2005-01-20       Impact factor: 9.776

7.  Amphiphilic beta-sheet cobra cardiotoxin targets mitochondria and disrupts its network.

Authors:  Chia-Hui Wang; Wen-guey Wu
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

8.  Structural difference between group I and group II cobra cardiotoxins: X-ray, NMR, and CD analysis of the effect of cis-proline conformation on three-fingered toxins.

Authors:  Ting-Shou Chen; Fong-Yu Chung; Siu-Cin Tjong; King-Siang Goh; Wei-Ning Huang; Kun-Yi Chien; Po-Long Wu; Hua-Ching Lin; Chun-Jung Chen; Wen-Guey Wu
Journal:  Biochemistry       Date:  2005-05-24       Impact factor: 3.162

9.  Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha.

Authors:  Sally E Stringer; Mark J Forster; Barbara Mulloy; Christopher R Bishop; Gerard J Graham; John T Gallagher
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

10.  Cardiotoxin-III selectively enhances activation-induced apoptosis of human CD8+ T lymphocytes.

Authors:  Shu-Hui Su; Shu-Jem Su; Shinne-Ren Lin; Kee-Lung Chang
Journal:  Toxicol Appl Pharmacol       Date:  2003-11-15       Impact factor: 4.219

View more
  5 in total

1.  Identification of a α-helical molten globule intermediate and structural characterization of β-cardiotoxin, an all β-sheet protein isolated from the venom of Ophiophagus hannah (king cobra).

Authors:  Amrita Roy; Sun Qingxiang; Chapeaurouge Alex; Nandhakishore Rajagopalan; Chacko Jobichen; J Sivaraman; R Manjunatha Kini
Journal:  Protein Sci       Date:  2019-04-04       Impact factor: 6.725

2.  S- and P-type cobra venom cardiotoxins differ in their action on isolated rat heart.

Authors:  Alexey S Averin; Mikhail V Goltyaev; Tatyana V Andreeva; Vladislav G Starkov; Victor I Tsetlin; Yuri N Utkin
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-04-04

3.  The myth of cobra venom cytotoxin: More than just direct cytolytic actions.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Toxicon X       Date:  2022-04-04

Review 4.  An Emergent Role for Mitochondrial Bioenergetics in the Action of Snake Venom Toxins on Cancer Cells.

Authors:  Félix A Urra; Dan E Vivas-Ruiz; Eladio Flores Sanchez; Ramiro Araya-Maturana
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

5.  Predicting antibacterial activity from snake venom proteomes.

Authors:  Justin L Rheubert; Michael F Meyer; Raeshelle M Strobel; Megan A Pasternak; Robert A Charvat
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.